Can you take melatonin after gastric sleeve surgery? It is a question many patients ask as they navigate sleep difficulties in the post-operative period. In the UK, melatonin is a prescription-only medicine — not available over the counter — and its use following sleeve gastrectomy is considered off-label. Whilst there is no specific contraindication from the MHRA or NICE, altered gastric anatomy can affect how certain formulations are absorbed, and important drug interactions must be considered. This article outlines what patients and clinicians need to know before using melatonin after gastric sleeve surgery.

How Gastric Sleeve Surgery Affects Medication Absorption

Gastric sleeve surgery removes 75–80% of the stomach, accelerating gastric transit and altering pH, which can reduce the reliability of modified-release and enteric-coated formulations; immediate-release or liquid preparations are preferred post-operatively.

Gastric sleeve surgery (sleeve gastrectomy) removes approximately 75–80% of the stomach, creating a narrow, tube-shaped pouch. This anatomical change has significant implications for how medications and supplements are absorbed. The reduced stomach volume means that transit time through the upper gastrointestinal tract is faster, which can affect how quickly and completely a substance is absorbed into the bloodstream.

For most oral medications, absorption primarily occurs in the small intestine rather than the stomach itself, so the impact of sleeve gastrectomy is generally less pronounced than with procedures such as Roux-en-Y gastric bypass, which physically bypasses a portion of the small intestine. However, the altered gastric environment — including changes in stomach acid production, gastric emptying rate, and gastric pH — can still influence the bioavailability of certain drugs and supplements. Many patients are prescribed a proton pump inhibitor (PPI) routinely after surgery; the resulting rise in gastric pH can affect the dissolution of acid-dependent formulations.

In line with guidance from the British Obesity and Metabolic Surgery Society (BOMSS), the following principles apply to medication use after gastric sleeve surgery:

• Prefer liquids or crushable immediate-release formulations in the early post-operative period, as these are more reliably absorbed

• Avoid modified-release (MR) and enteric-coated (EC) preparations in the early post-operative months, as altered gastric motility and pH may impair their intended release profile

• Avoid large tablets (greater than approximately 10 mm) in the early post-operative period, as these may not dissolve adequately

• Liquid or chewable alternatives are often better tolerated and more reliably absorbed early on

• Nutrient deficiencies: Reduced intake and altered absorption can affect levels of vitamins and minerals, which may indirectly influence sleep and overall wellbeing

Patients are generally advised by their bariatric team to review all medications and supplements after surgery. This includes over-the-counter and prescription products alike, as well as supplements such as melatonin, which can still be subject to altered absorption dynamics following significant gastrointestinal surgery. Any changes to your medicines should be discussed with your bariatric team or GP.

Melatonin After Bariatric Surgery: What the Evidence Says

There is no MHRA or NICE contraindication to melatonin after gastric sleeve, but use is off-label, evidence is limited, and clinically significant interactions — particularly with fluvoxamine — require prescriber review before starting.

Melatonin is a naturally occurring hormone produced by the pineal gland in response to darkness. It plays a central role in regulating the sleep-wake cycle (circadian rhythm). In the UK, melatonin is a prescription-only medicine — it is not available over the counter. The licensed product Circadin (melatonin 2 mg prolonged-release) is indicated for the short-term treatment of primary insomnia in adults aged 55 and over, for up to 13 weeks. Other uses — including use in younger adults and use following bariatric surgery — are off-label and must be supervised by a clinician using a UK-licensed product. Patients should not purchase melatonin from unregulated online sources, as product quality and dose accuracy cannot be guaranteed.

There is currently limited high-quality clinical evidence specifically examining melatonin use following gastric sleeve surgery. Melatonin is a small lipophilic molecule and, in immediate-release form, is generally well absorbed across the gastrointestinal tract. However, prolonged-release formulations such as Circadin may behave less predictably after sleeve gastrectomy due to altered gastric motility and pH; this should be discussed with your prescriber. Some research in bariatric populations has explored melatonin's potential antioxidant and metabolic benefits beyond sleep, though these findings remain preliminary and should not be interpreted as established clinical guidance.

There is no official contraindication from the MHRA or NICE specifically prohibiting melatonin use after gastric sleeve surgery. However, the absence of a contraindication does not constitute a formal recommendation, and use in this context is off-label.

Patients should be aware of the following important considerations:

• Drug interactions: Melatonin is metabolised primarily by the liver enzyme CYP1A2. Fluvoxamine (an antidepressant) is a potent CYP1A2 inhibitor and is contraindicated or should be avoided with melatonin, as it can increase melatonin levels dramatically. Other CYP1A2 inhibitors — including ciprofloxacin and cimetidine — may also increase melatonin levels. CYP1A2 inducers such as rifampicin and carbamazepine, as well as smoking, can reduce melatonin levels. Oestrogens (including combined oral contraceptives) may increase melatonin levels. Melatonin may interact with anticoagulants such as warfarin (monitor INR closely), immunosuppressants, and other central nervous system (CNS) depressants (additive sedation). Avoid alcohol whilst taking melatonin.

• Driving and operating machinery: Melatonin may cause drowsiness. Do not drive or operate machinery until you know how melatonin affects you.

• Special populations: Seek medical advice before using melatonin if you are pregnant or breastfeeding. Use with caution — and only on specialist advice — in autoimmune disease, epilepsy, hepatic impairment, or renal impairment.

• Underlying causes of poor sleep: Sleep disturbance after surgery may have specific causes that melatonin alone will not address.

• Individual variation: Absorption and response to melatonin may vary between individuals, particularly in the early post-operative period.

Always discuss melatonin use with your bariatric team or GP before starting, and use only UK-licensed products as directed by your prescriber.

Recommended Forms and Doses Following Gastric Sleeve

Immediate-release melatonin formulations are preferred after gastric sleeve surgery; Circadin (prolonged-release) must not be crushed and may be less suitable early post-operatively, so discuss alternatives with your prescriber.

Following gastric sleeve surgery, the form in which you take any supplement or medication matters considerably. In line with BOMSS guidance, modified-release and enteric-coated preparations should generally be avoided in the early post-operative period, as altered gastric motility and pH can impair their intended release profile. For this reason, immediate-release formulations are preferred where available.

With regard to melatonin specifically, the following points apply in the UK context:

• Circadin (melatonin 2 mg prolonged-release tablets): This is the principal UK-licensed melatonin product. Because it is a modified-release preparation, it must be swallowed whole and must not be crushed or chewed. In the early post-operative period, this formulation may be less suitable; discuss with your prescriber whether an immediate-release alternative is more appropriate for you.

• Immediate-release melatonin (oral solution or tablets): Where a prescriber considers melatonin appropriate after sleeve gastrectomy, an immediate-release licensed oral solution or tablet is generally preferable in the early post-operative period, as absorption is less likely to be affected by altered gastric motility.

• Chewable, gummy, or sublingual products: Many such products available online or in health food shops are not licensed medicines in the UK and may be sold unlawfully as food supplements. Their melatonin content, quality, and dose accuracy are not guaranteed. Patients should not purchase these products and should use only UK-licensed preparations prescribed by a clinician.

• Sublingual absorption: Some products claim to be absorbed under the tongue, but evidence for complete sublingual absorption of melatonin is limited and variable; a significant proportion of the dose is likely swallowed and absorbed via the gastrointestinal tract. Do not assume that sublingual products bypass gastrointestinal absorption entirely.

• Sugar content: If a liquid formulation is prescribed, check whether it is sugar-free, particularly given the metabolic goals of bariatric surgery and the risk of dumping syndrome with high-sugar preparations.

In terms of dosage, the licensed dose of Circadin is 2 mg taken one to two hours before bedtime. If an immediate-release formulation is prescribed off-label, your prescriber will advise on an appropriate starting dose — typically low (for example, 1–2 mg). Higher doses do not necessarily produce better results and may cause next-day drowsiness, headache, or dizziness. A short trial of two to four weeks is reasonable; if there is no benefit, melatonin should be stopped and the cause of sleep difficulty reassessed. Always follow the guidance of your prescriber or bariatric team when selecting a formulation and dose.

Sleep Difficulties After Bariatric Surgery and Possible Causes

Sleep disturbance after gastric sleeve can result from nutritional deficiencies, hormonal changes, gastro-oesophageal reflux, sleep apnoea, or psychological factors, all of which should be assessed before starting melatonin.

Sleep disturbance is a commonly reported experience following bariatric surgery, including gastric sleeve procedures. Whilst many patients hope that weight loss will improve sleep — and it often does, particularly in those with obesity-related obstructive sleep apnoea (OSA) — the post-operative period itself can introduce new or temporary sleep challenges.

Several factors may contribute to poor sleep after gastric sleeve surgery:

• Nutritional deficiencies: Low levels of magnesium, vitamin B12, folate, vitamin D, iron (ferritin), and thiamine — all of which can occur after bariatric surgery — can impair sleep quality and duration. Thiamine (vitamin B1) deficiency is an urgent concern in patients experiencing persistent vomiting alongside fatigue, confusion, or neurological symptoms; seek prompt medical assessment if these features are present. If nutritional deficiency is suspected, your GP or bariatric team should arrange appropriate blood tests (for example, full blood count, ferritin, B12, folate, vitamin D, and magnesium).

• Hormonal changes: Rapid weight loss triggers significant hormonal shifts, including changes in cortisol, oestrogen, and ghrelin, all of which can affect sleep architecture.

• Gastro-oesophageal reflux: Sleeve gastrectomy can worsen or precipitate reflux, which may disrupt sleep. Practical measures include avoiding eating close to bedtime, sleeping with the head of the bed elevated, and reviewing PPI therapy with your GP or bariatric team.

• Gastrointestinal discomfort: Symptoms such as nausea or early dumping syndrome may disrupt sleep, particularly if eating patterns are not yet well established.

• Psychological factors: Anxiety, low mood, and adjustment difficulties are not uncommon after major surgery and can significantly affect sleep.

• Residual or undiagnosed sleep apnoea: Weight loss may reduce but not always eliminate OSA. Some patients may require reassessment with a formal sleep study (in line with NICE NG202). If you experience loud snoring, witnessed pauses in breathing, or excessive daytime sleepiness, do not drive until formally assessed, and discuss this with your GP promptly.

Understanding the root cause of sleep difficulties is essential before starting any treatment. Melatonin may be helpful for circadian rhythm disruption or difficulty initiating sleep, but it is unlikely to resolve sleep problems rooted in nutritional deficiency, untreated reflux, or sleep apnoea. A thorough review with your bariatric team can help identify the most appropriate intervention.

When to Seek Advice From Your Bariatric Team or GP

Consult your bariatric team or GP before starting melatonin after gastric sleeve surgery, particularly if you take fluvoxamine, warfarin, or immunosuppressants, or if sleep difficulties persist beyond two to four weeks.

Melatonin is a prescription-only medicine in the UK. It should only be used under the supervision of a clinician, using a UK-licensed product, and its use after gastric sleeve surgery is off-label. Always consult your bariatric team or GP before starting melatonin or any new supplement following surgery. This is particularly important if you are taking prescription medications, given the interaction profile described above — especially if you take fluvoxamine (avoid concurrent use), warfarin (monitor INR), immunosuppressants, or other medicines that cause sedation.

Additional safety points to discuss with your clinician:

• Alcohol: Avoid alcohol whilst taking melatonin.

• Driving and machinery: Do not drive or operate machinery until you know how melatonin affects you, as it may cause drowsiness.

• Pregnancy and breastfeeding: Seek medical advice before use; melatonin is not recommended during pregnancy or breastfeeding.

• Autoimmune disease, epilepsy, hepatic or renal impairment: Use only on specialist advice in these circumstances.

• Duration of use: A short trial of two to four weeks is appropriate; stop melatonin if there is no benefit and discuss alternative approaches with your clinician.

You should seek prompt advice from your GP or bariatric team if you experience any of the following:

• Persistent or worsening sleep difficulties lasting more than two to four weeks, which may indicate an underlying medical or psychological cause requiring assessment

• Symptoms suggestive of nutritional deficiency, such as fatigue, low mood, hair loss, or tingling in the hands and feet — these warrant blood tests and targeted supplementation

• Persistent vomiting with fatigue, confusion, or neurological symptoms — seek urgent assessment for possible thiamine deficiency

• Signs of obstructive sleep apnoea, including loud snoring, witnessed apnoeas, or excessive daytime sleepiness — do not drive until formally assessed

• Side effects from melatonin, such as prolonged drowsiness, vivid dreams, headaches, or mood changes

• Any new medication or supplement you are considering, to ensure it is appropriate in your post-operative context

If you experience a suspected side effect from melatonin or any other medicine, you can report it directly to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Experiencing these side effects? Our pharmacists can help you navigate them →

Your bariatric team — which may include a surgeon, specialist nurse, dietitian, and psychologist — is best placed to provide personalised guidance. Most NHS bariatric programmes offer ongoing follow-up appointments specifically to address concerns such as sleep, nutrition, and supplement use. Do not hesitate to raise sleep concerns at your next review, as addressing them early can significantly support your long-term recovery and wellbeing.

Frequently Asked Questions